1
|
Moding EJ, Kastan MB and Kirsch DG:
Strategies for optimizing the response of cancer and normal tissues
to radiation. Nat Rev Drug Discov. 12:526–542. 2013. View Article : Google Scholar : PubMed/NCBI
|
2
|
Wang JS, Wang HJ and Qian HL: Biological
effects of radiation on cancer cells. Mil Med Res.
5:202018.PubMed/NCBI
|
3
|
Wang H, Mu X, He H and Zhang XD: Cancer
radiosensitizers. Trends Pharmacol Sci. 39:24–48. 2018. View Article : Google Scholar
|
4
|
Sokolov M and Neumann R: Effects of low
doses of ionizing radiation exposures on stress-responsive gene
expression in human embryonic stem cells. Int J Mol Sci.
15:588–604. 2014. View Article : Google Scholar : PubMed/NCBI
|
5
|
Nowsheen S and Yang ES: The intersection
between DNA damage response and cell death pathways. Exp Oncol.
34:243–254. 2012.PubMed/NCBI
|
6
|
Xu J, Liu D, Zhao D, Jiang X, Meng X,
Jiang L, Yu M, Zhang L and Jiang H: Role of low-dose radiation in
senescence and aging: A beneficial perspective. Life Sci.
302:1206442022. View Article : Google Scholar : PubMed/NCBI
|
7
|
Ossetrova NI and Blakely WF: Multiple
blood-proteins approach for early-response exposure assessment
using an in vivo murine radiation model. Int J Radiat Biol.
85:837–850. 2009.PubMed/NCBI
|
8
|
Zhang M, Yin L, Zhang K, Sun W, Yang S,
Zhang B, Salzman P, Wang W, Liu C, Vidyasagar S, et al: Response
patterns of cytokines/chemokines in two murine strains after
irradiation. Cytokine. 58:169–177. 2012. View Article : Google Scholar : PubMed/NCBI
|
9
|
Mathias D, Mitchel RE, Barclay M, Wyatt H,
Bugden M, Priest ND, Whitman SC, Scholz M, Hildebrandt G, Kamprad M
and Glasow A: Low-dose irradiation affects expression of
inflammatory markers in the heart of ApoE -/- mice. PLoS One.
10:e01196612015. View Article : Google Scholar : PubMed/NCBI
|
10
|
Marchetti F, Coleman MA, Jones IM and
Wyrobek AJ: Candidate protein biodosimeters of human exposure to
ionizing radiation. Int J Radiat Biol. 82:605–639. 2006. View Article : Google Scholar : PubMed/NCBI
|
11
|
Gu J, Chen YZ, Zhang ZX, Yang ZX, Duan GX,
Qin LQ, Zhao L and Xu JY: At what dose can total body and whole
abdominal irradiation cause lethal intestinal injury among C57BL/6J
mice? Dose Response. 18:15593258209567832020. View Article : Google Scholar : PubMed/NCBI
|
12
|
Pan Z, Zhang X, Yu P, Chen X, Lu P, Li M,
Liu X, Li Z, Wei F, Wang K, et al: Cinobufagin induces cell cycle
arrest at the G2/M phase and promotes apoptosis in malignant
melanoma cells. Front Oncol. 9:8532019. View Article : Google Scholar : PubMed/NCBI
|
13
|
Grahn D and Hamilton KF: Genetic variation
in the acute lethal response of four inbred mouse strains to whole
body X-irradiation. Genetics. 42:189–198. 1957. View Article : Google Scholar : PubMed/NCBI
|
14
|
Soto-Pantoja DR, Ridnour LA, Wink DA and
Roberts DD: Blockade of CD47 increases survival of mice exposed to
lethal total body irradiation. Sci Rep. 3:10382013. View Article : Google Scholar : PubMed/NCBI
|
15
|
Li L, Xiao R, Wang Q, Rong Z, Zhang X,
Zhou P, Fu H, Wang S and Wang Z: SERS detection of radiation injury
biomarkers in mouse serum. RSC Adv. 8:5119–5126. 2018. View Article : Google Scholar : PubMed/NCBI
|
16
|
Ito Y, Kinoshita M, Yamamoto T, Sato T,
Obara T, Saitoh D, Seki S and Takahashi Y: A combination of pre-
and post-exposure ascorbic acid rescues mice from radiation-induced
lethal gastrointestinal damage. Int J Mol Sci. 14:19618–19635.
2013. View Article : Google Scholar : PubMed/NCBI
|
17
|
Nunamaker EA, Artwohl JE, Anderson RJ and
Fortman JD: Endpoint refinement for total body irradiation of
C57BL/6 mice. Comp Med. 63:22–28. 2013.PubMed/NCBI
|
18
|
Mettler FA: Medical effects and risks of
exposure to ionising radiation. J Radiol Prot. 32:N9–N13. 2012.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Seo S, Lee D, Seong KM, Park S, Kim SG,
Won JU and Jin YW: Radiation-related occupational cancer and its
recognition criteria in South Korea. Ann Occup Environ Med.
30:92018. View Article : Google Scholar : PubMed/NCBI
|
20
|
Allan JM and Travis LB: Mechanisms of
therapy-related carcinogenesis. Nat Rev Cancer. 5:943–955. 2005.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Little JB: Radiation carcinogenesis.
Carcinogenesis. 21:397–404. 2000. View Article : Google Scholar : PubMed/NCBI
|
22
|
Barcellos-Hoff MH and Nguyen DH: Radiation
carcinogenesis in context: How do irradiated tissues become tumors?
Health Phys. 97:446–457. 2009. View Article : Google Scholar : PubMed/NCBI
|
23
|
Huang L, Snyder AR and Morgan WF:
Radiation-induced genomic instability and its implications for
radiation carcinogenesis. Oncogene. 22:5848–5854. 2003. View Article : Google Scholar : PubMed/NCBI
|
24
|
Obrador E, Salvador-Palmer R, Villaescusa
JI, Gallego E, Pellicer B, Estrela JM and Montoro A: Nuclear and
radiological emergencies: biological effects, countermeasures and
biodosimetry. Antioxidants (Basel). 11:10892022.
|
25
|
Turtoi A, Brown I, Oskamp D and
Schneeweiss FHA: Early gene expression in human lymphocytes after
gamma-irradiation-a genetic pattern with potential for
biodosimetry. Int J Radiat Biol. 84:375–387. 2008. View Article : Google Scholar : PubMed/NCBI
|
26
|
Brengues M, Paap B, Bittner M, Amundson S,
Seligmann B, Korn R, Lenigk R and Zenhausern F: Biodosimetry on
small blood volume using gene expression assay. Health Phys.
98:179–185. 2010. View Article : Google Scholar : PubMed/NCBI
|
27
|
Dainiak N: Hematologic consequences of
exposure to ionizing radiation. Exp Hematol. 30:513–528. 2002.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Shiloh Y and Ziv Y: The ATM protein
kinase: Regulating the cellular response to genotoxic stress, and
more. Nat Rev Mol Cell Biol. 14:197–210. 2013. View Article : Google Scholar : PubMed/NCBI
|
29
|
Goodarzi AA, Noon AT, Deckbar D, Ziv Y,
Shiloh Y, Löbrich M and Jeggo PA: ATM signaling facilitates repair
of DNA double-strand breaks associated with heterochromatin. Mol
Cell. 31:167–177. 2008. View Article : Google Scholar : PubMed/NCBI
|
30
|
Helleday T, Petermann E, Lundin C, Hodgson
B and Sharma RA: DNA repair pathways as targets for cancer therapy.
Nat Rev Cancer. 8:193–204. 2008. View
Article : Google Scholar : PubMed/NCBI
|
31
|
Jackson SP and Bartek J: The DNA-damage
response in human biology and disease. Nature. 461:1071–1078. 2009.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Niu J, Wang J, Zhang Q, Zou Z and Ding Y:
Cinobufagin-induced DNA damage response activates G2/M
checkpoint and apoptosis to cause selective cytotoxicity in cancer
cells. Cancer Cell Int. 21:4462021. View Article : Google Scholar
|
33
|
Li Y, Lin J, Xiao J, Li Z, Chen JS, Wei L
and Wang X: Therapeutic effects of co-Venenum bufonis oral liquid
on radiation-induced esophagitis in rats. Exp Anim. 69:354–362.
2020. View Article : Google Scholar : PubMed/NCBI
|
34
|
Xie S, Spelmink L, Codemo M, Subramanian
K, Pütsep K, Henriques-Normark B and Olliver M: Cinobufagin
modulates human innate immune responses and triggers antibacterial
activity. PLoS One. 11:e01607342016. View Article : Google Scholar : PubMed/NCBI
|
35
|
Peng P, Lv J, Cai C, Lin S, Zhuo E and
Wang S: Cinobufagin, a bufadienolide, activates ROS-mediated
pathways to trigger human lung cancer cell apoptosis in vivo. RSC
Adv. 7:25175–25181. 2017. View Article : Google Scholar
|
36
|
Niu T, Zhao L, Lin X, Cai Y, Chen S, Wang
M, Zhou L, Ding H and Yu X: Cinobufagin, a bufadienolide from
traditional Chinese medicine Bufo bufo gargarizans CANTOR, inhibits
PC3 cell growth in vitro and in vivo. J Tradit Chin Med Sci.
6:175–183. 2019.
|
37
|
Wu SC, Yi PF, Guo X, Zhang LY, Xu DX, Fu
YX, Cui ZQ, Shen HQ, Wei XB and Fu BD: Cinobufagin enhances the
protective efficacy of formalin-inactivated Salmonella typhimurium
vaccine through Th1 immune response. Microb Pathog. 99:264–270.
2016. View Article : Google Scholar : PubMed/NCBI
|
38
|
Yu Y, Wang H, Meng X, Hao L, Fu Y, Fang L,
Shen D, Yu X and Li J: Immunomodulatory effects of cinobufagin on
murine lymphocytes and macrophages. Evid Based Complement Alternat
Med. 2015:8352632015. View Article : Google Scholar : PubMed/NCBI
|
39
|
Matsuoka S, Huang M and Elledge SJ:
Linkage of ATM to cell cycle regulation by the Chk2 protein kinase.
Science. 282:1893–1897. 1998. View Article : Google Scholar : PubMed/NCBI
|
40
|
Hirao A, Kong YY, Matsuoka S, Wakeham A,
Ruland J, Yoshida H, Liu D, Elledge SJ and Mak TW: DNA
damage-induced activation of p53 by the checkpoint kinase Chk2.
Science. 287:1824–1827. 2000. View Article : Google Scholar : PubMed/NCBI
|
41
|
Melchionna R, Chen XB, Blasina A and
McGowan CH: Threonine 68 is required for radiation-induced
phosphorylation and activation of Cds1. Nat Cell Biol. 2:762–765.
2000. View Article : Google Scholar : PubMed/NCBI
|
42
|
Sancar A, Lindsey-Boltz LA, Unsal-Kaçmaz K
and Linn S: Molecular mechanisms of mammalian DNA repair and the
DNA damage checkpoints. Annu Rev Biochem. 73:39–85. 2004.
View Article : Google Scholar : PubMed/NCBI
|
43
|
Rainey MD, Black EJ, Zachos G and
Gillespie DAF: Chk2 is required for optimal mitotic delay in
response to irradiation-induced DNA damage incurred in G2 phase.
Oncogene. 27:896–906. 2008. View Article : Google Scholar
|
44
|
Nguyen TNT, Saleem RSZ, Luderer MJ, Hovde
S, Henry RW and Tepe JJ: Radioprotection by hymenialdisine-derived
checkpoint kinase 2 inhibitors. ACS Chem Biol. 7:172–184. 2012.
View Article : Google Scholar
|
45
|
Zahmatkesh MH, Hosseinimehr SJ and
Mahdiuni H: Role of CHK2 inhibitors in the cellular responses to
ionizing radiation. Mini Rev Med Chem. 14:812–818. 2014. View Article : Google Scholar : PubMed/NCBI
|
46
|
Arienti KL, Brunmark A, Axe FU, McClure K,
Lee A, Blevitt J, Neff DK, Huang L, Crawford S, Pandit CR, et al:
Checkpoint kinase inhibitors: SAR and radioprotective properties of
a series of 2-arylbenzimidazoles. J Med Chem. 48:1873–1885. 2005.
View Article : Google Scholar : PubMed/NCBI
|
47
|
Takai H, Naka K, Okada Y, Watanabe M,
Harada N, Saito S, Anderson CW, Appella E, Nakanishi M, Suzuki H,
et al: Chk2-deficient mice exhibit radioresistance and defective
p53-mediated transcription. EMBO J. 21:5195–5205. 2002. View Article : Google Scholar : PubMed/NCBI
|
48
|
Jung SY, Park JI, Jeong JH, Song KH, Ahn
J, Hwang SG, Kim J, Park JK, Lim DS and Song JY: Receptor
interacting protein 1 knockdown induces cell death in liver cancer
by suppressing STAT3/ATR activation in a p53-dependent manner. Am J
Cancer Res. 12:2594–2611. 2022.PubMed/NCBI
|
49
|
Joerger AC and Fersht AR: The p53 pathway:
Origins, inactivation in cancer, and emerging therapeutic
approaches. Annu Rev Biochem. 85:375–404. 2016. View Article : Google Scholar : PubMed/NCBI
|